_(52748025943).png)
_(cropped)-(1).jpg)
Sixteen-year-old dies after receiving Sarepta’s Duchenne therapy Elevidys
A teenage boy who received Sarepta’s Duchenne muscular dystrophy gene therapy Elevidys died from liver failure, the biotech said Tuesday morning. Sarepta told Endpoints News he was 16 years old and was treated in December ...
A teenage boy who received Sarepta’s Duchenne muscular dystrophy gene therapy Elevidys died from liver failure, the biotech said Tuesday morning.
Sarepta told Endpoints News he was 16 years old and was treated in December ...
